Christoph Eberle

Principal Scientist, Oncology
Worcester, MA

Christoph works as a principal scientist with the in vivo pharmacology team at Charles River Massachusetts (CRMA). In his role, he oversees T-cell isolations for adoptive transfers and immunophenotyping of tissue samples collected from various mouse models (syngeneic and humanized). Trained as biochemist, he specialized in flow cytometry assay development and validation across pre-clinical and clinical operations. In 2008, Christoph received his PhD in Organic Chemistry from the University of Bremen (Germany). He is a professional member of the Institute of Clinical Research (ICR) in the United Kingdom and is involved in the International Society for Advancement of Cytometry (ISAC). Prior to joining Charles River in 2017, he held positions at Envigo and Eurofins Central Laboratory.